Bio Rad Laboratories Inc (BIO) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bio rad Laboratories Inc   (NYSE: BIO)


Bio Rad Laboratories Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bio Rad Laboratories Inc 's ROA in the second quarter of 2026?
Bio rad Laboratories Inc achieved a return on average assets (ROA) of 2.25 % in its second quarter of 2026, which is below Bio Rad Laboratories Inc 's average return on assets, which stands at 4.84%.

ROA has improved compared to 1.72% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 186 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 950 to 1915.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 2.25 % 4.43 % 19.08 % -8.76 % 5.45 %
Y / Y Net Income Change 16.87 % - - - -
Net Income (TTM) in million 222 169 760 -676 319
Return On Assets (TTM) 2.25 % 1.72 % 7.82 % -7.26 % 3.34 %
BIO's Total Ranking # 1915 # 950 # 3155 # 1527 # 3670
Total Assets (TTM) in million 10,252 9,790 9,939 9,518 10,026
Seq. Total Assets Change 4.72 % -1.5 % 4.42 % -5.07 % 6.95 %
Seq. Net Income Change - - - - 396.56 %

BIO's 5 Years Annual ROA >> Back to BIO Management Effectiveness >> Compare BIO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 187
Overall # 1771

Return On Assets Statistics
High Average Low
42.98 %
4.84 %
-42.43 %
(Sep 30 2021)   (Sep 30 2022)





Financial Statements
Bio Rad Laboratories Inc 's Assets $ 10,252 million BIO's Balance sheet
Bio Rad Laboratories Inc 's Income $ 371 million Quarterly BIO's Income Statement
BIO's Income by Division See BIO's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 81.19 % -23.96 % -9.14 % -24.18 % 37.58 %
Total Assets in million 16,680 9,206 12,106 13,324 17,573
Y / Y Net Income Change - - - - 11.55 %
Net Income in million 760 -1,844 -637 -3,628 4,246
Annual Return On Assets 4.56 % -20.03 % -5.26 % -27.23 % 24.16 %

BIO's 5 Years Annual ROA >> Back to BIO Management Effectiveness >> Compare BIO ROA to its Competitors



Comment on BIO's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 4.56 % compared to prior year, due to annual net income growth of % to $759.90 million, while value of Bio Rad Laboratories Inc 's overall assets grew just by 81.19 % to $16,680.10 million, compared to $16,680.10 a year before.


More Return On Assets Ratios
BIO's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIO's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BIO's Competitors
Subscribers only: Roa for Bio Rad Laboratories Inc 's Suppliers
Subscribers only: Return On Assets for BIO's Customers

You may also want to know
BIO's Roi BIO's Inventory Turnover Ratio BIO's Growth Rates BIO's Dividend Comparisons
BIO's Profitability Ratios BIO's Asset Turnover Ratio BIO's Dividend Growth
BIO's Roe BIO's Valuation Ratios BIO's Financial Strength Ratios BIO's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Brightspring Health Services Inc   5.93 %
Amneal Pharmaceuticals Inc   5.90 %
Siga Technologies Inc  5.73 %
Medtronic Plc  5.71 %
Labcorp Holdings Inc   5.40 %
Merit Medical Systems Inc  5.34 %
Sotera Health Company  5.03 %
Vericel Corporation  5.02 %
Kewaunee Scientific Corporation  4.96 %
Pacs Group Inc   4.78 %
Amphastar Pharmaceuticals Inc   4.70 %
Abbvie Inc   4.68 %
The Cooper Companies Inc   4.57 %
IMPACT BIOMEDICAL INC.  4.47 %
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %

Date modified: 2026-09-12T06:19:38+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.